| Company | Title |
| Abwiz Bio, Inc. | Antibody Affinity Maturation by Steam Technology and Next-Generation WizAmp™ Antibody Discovery Platform for Mouse and Rabbit mAbs |
| Accelero Biostructures, Inc. | Experimental Lead Generation by Crystallographic Screening of Fragment Libraries |
| Aptamer Sciences, Inc. | Introducing Aptamer-Based Lead Generation Platforms, Targeting Plasma Membrane Proteins |
| BellBrook Labs | Interrogating CD39 for Small Molecule Inhibitors Using the Transcreener® Assay Platform |
| BellBrook Labs | Targeting cGAS for Type 1 Interferon-Driven Autoimmune Diseases |
| BellBrook Labs | Transcreener CD73 Assay: A High Throughput, Sensitive Assay to Measure Adenosine |
| BellBrook Labs | Using A Universal Kinase Assay for Both HTS and Hit-to-Lead |
| BioAscent Discovery Ltd. | Thermal Shift Indicates that Oxalic Acid Is a Prevalent Contaminant of Hits Identified by High Throughput Screening |
| BPS Bioscience, Inc. | Biochemical Assay Kits for High-Throughput PROTAC Optimization |
| CALIXAR | Stabilization of Native Membrane Proteins for Drug Discovery: Case Studies for a GPCR, Ion Channel and Transporter Targets |
| CALIXAR | Biochemical and Biophysical Characterization of Purified Native CD20 Alone and in Complex with Rituximab and Obinutuzumab |
| Cellecta, Inc. | Combining Cell Barcoding and CRISPR sgRNA Libraries with Targeted Gene Expression for Single-Cell Genetic Analysis of Tumor Progression |
| Chemical Computing Group | MOEsaic: Application of Matched Molecular Pairs to Interactive SAR Exploration |
| Chemical Computing Group | Structure-Based Predictions of CYP Selectivity, Reactivity, and Regioselectivity |
| Chinese University of Hong Kong | A Peptidylic Inhibitor for Neutralizing Repeat Expansion-Associated Neurodegeneration |
| Daegu Gyeongbuk Medical Innovation Foundation (DGMIF) | Synthesis of Imidazopyridine Derivatives as Type II Inhibitors Targeting T315I-Mutated BCR-ABL |
| Daegu Gyeongbuk Medical Innovation Foundation (DGMIF) | Discovery of 2,4-Disubstituted Pyrimidine Derivatives as T790M EGFR Inhibitor |
| Eternity Bioscience, Inc. | A Novel RORγ Antagonist Exhibits Excellent Topical Efficacy in Preclinical Animal Models for Psoriasis |
| Eurofins Discovery | Novel, Improved Cell-Based Assays to Enable Immunotherapy Drug Development for Checkpoint Receptors |
| Eurofins Discovery | Biosensor Development Using CRISPR to Quantify Endogenous Protein Expression Modulated by PROTACs |
| Eurofins Discovery | GPCR Allosteric Modulation: Another Shot on Goal |
| Eurofins Discovery | Validation of a Label-Free Mass Spectrometry-Based Binding Assay for the Gamma-Aminobutyric Acid B 1b Receptor |
| Eurofins Discovery | Improving Valvulopathy Prediction by Qualifying 5-HT2B Functional Assay Technologies |
| GenScript USA, Inc. | A Novel Method for Constructing Diverse Variant Libraries with Precise Codon Ratio Control |
| Hallym University | Histone Deacetylase 6 Inhibitor Tubastatin A Attenuates Angiotensin II-Induced Hypertension by Preventing Cystathionine Gamma-Lyase Protein Degradation |
| Hybrigenics Corporation | Development of a Robust, Exhaustive Y2H-Based Screening Platform to Identify Novel Chemically Induced Protein-Protein Interactions |
| Industrial Technology Research Institute | ITRI-E-4046, a Potent Ocular Hypotensive Agent for the Treatment of Glaucoma |
| InterAx Biotech AG | Integrating Experimental and Computational Pharmacology for Intelligent Drug Design |
| IONTAS Ltd. | Generating Potent and Selective Inhibitors of Kv1.3 Ion Channel by Fusing Venom Derived Mini Proteins into Peripheral CDR Loops of Antibodies |
| Korea Research Institute of Bioscience and Biotechnology | A Novel Cereblon Modulator for Targeted Protein Degradation |
| leadXpro AG | Gene to Structure Pipeline at leadXpro to Tackle Drug Discovery on Membrane Proteins Targets |
| Life Chemicals, Inc. | Novel Fragment Libraries from Life Chemicals |
| Life Chemicals, Inc. | Screening Compound Libraries for HTS and Lead Discovery Projects |
| Ligand OmniAb | The Next Generation Transgenic Chicken for Bispecific Antibody Applications |
| Memorial Sloan Kettering Cancer Center | A Strategy for PROTAC Delivery for Cancer Therapy |
| Montana Molecular | Real-Time Kinetic Analysis of GPCR Signaling in Stable PathHunter® Cell Lines |
| Myongji University | Novel and Unique Extended-Spectrum β-Lactamases from Gram-Negative Pathogens as a Drug Target |
| National Institute of Health Sciences | Design and Synthesis of 4-(2-Heteroaryl)-4-Phenylheptane Derivatives as Estrogen Receptor Ligands |
| National Institutes of Health, National Center for Advancing Translational Sciences | Identifying New Drug Targets by Illuminating the Druggable Genome |
| National Institutes of Health, National Institute on Alcohol Abuse and Alcoholism | Radioligand Thermostability Assessment of Agonist-Bound Human Type 2 Cannabinoid Receptor |
| National Research Council Canada | Structure-Based Engineering of pH-Dependent Antibody Binding for Selective Targeting of Tumor Microenvironment |
| National University of Colombia/Universidad Nacional de Colombia | Isoquinoline Alkaloids from Zanthoxylum rigidum as Potential Multi-Target Neuroprotective Ligands for the Treatment of Alzheimer's Disease |
| National University of Singapore | Targeting SALL4 via Small Molecule Drug in Cancer |
| NB Health Laboratory Co., Ltd. | Discovery of the Functional Therapeutic mAbs Targeting GPCRs with a Unique Single Cell Analysis Technique |
| Peak Proteins Ltd. | G6b-B: A New Receptor for Platelet Production and Function |
| Pharmechanics LLC | A New Pharmacological Method for Quantifying Signaling Kinetics and Biased Agonism |
| Promega Corporation | Profiling a Large Kinase Enzyme Mutant Collection Using the Luminescent ADP Detection Platform |
| Promega Corporation | Interrogating Signaling Pathways with Novel Homogeneous Cell Based NanoBiT Immunoassays |
| Promega Corporation | NanoBRET™ in Live Cells as a Method to Assess E3 Ligase and Target Protein Occupancy for PROTACs |
| Promega Corporation | Chemical Proteomic Strategy Utilizing a Photoreactive Chloroalkane Capture Tag for Target Discovery |
| Promega Corporation | Novel Bioluminescent Tools to Study GPCR Pharmacology in Living Cells |
| Roche Diagnostics GmbH | Interaction Studies for Therapeutic Antibodies Targeting Transmembrane Proteins |
| Salipro Biotech AB | The Salipro® System for Stabilization of Membrane Proteins |
| SAMDI Tech, Inc. | Label-Free Assays Using SAMDI Mass Spectrometry for Regulators of Phosphorylation: From Proteins to Cells |
| SARomics Biostructures AB | Fragment Screening of USP7 by Weak Affinity Chromatography (WAC) |
| Seoul National University | Discovery of a New Small Molecule Reducing Lipid Droplets by Selective Autophagy Activation |
| SGI-DNA, Inc. | Rapid Assembly of Synthetic DNA Libraries for Protein Engineering and Generating Antibody Diversity |
| SpiroChem | Bioisosteric Replacements in Drug Discovery |
| Standigm | AI Driven Repurposed Drugs for NASH Treatment |
| Sygnature Discovery Ltd. | Identification of Novel Inhibitors of the RNA Demethylase Fat Mass and Obesity Associated Protein (FTO) by Microscale Thermophoresis |
| Symphogen A/S | A Fully Integrated Platform for Functional Deep Mining of Antibody Repertoires from a Variety of Species to Secure Clinical Lead Candidate Antibodies Against Conserved and Difficult Targets |
| TNO - The Netherlands Organization for Applied Scientific Research | Improved Preclinical Translation by Metabolome and Transcriptome Disease Signatures of NASH Patients |
| TNO - The Netherlands Organisation for Applied Scientific Research | A Discovery and Evaluation Workflow to Identify Novel Targets for NASH-Induced Liver Fibrosis |
| TNO - The Netherlands Organization for Applied Scientific Research | A Translational Mouse Model for NASH and Advanced Fibrosis in Association with Atherosclerosis |
| Twist BioScience | A High-Throughput Platform to Develop Potent and Functional Antibodies against G-protein Coupled Receptors |
| Vaccinex, Inc. | Use of Mammalian Virus Display to Select Antibodies Specific for Complex Membrane Antigens |
| Vanderbilt University | Fragment Based Molecular Discovery Approach to RAGE Inhibitors |